Follow
Dr Peter M. Wilson
Dr Peter M. Wilson
CV6 Therapeutics NI Ltd
Verified email at cv6t.com
Title
Cited by
Cited by
Year
Standing the test of time: targeting thymidylate biosynthesis in cancer therapy
PM Wilson, PV Danenberg, PG Johnston, HJ Lenz, RD Ladner
Nature reviews Clinical oncology 11 (5), 282-298, 2014
5472014
Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
Y Ning, PC Manegold, YK Hong, W Zhang, A Pohl, G Lurje, T Winder, ...
International journal of cancer 128 (9), 2038-2049, 2011
5282011
Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan
J Boyer, EG McLean, S Aroori, P Wilson, A McCulla, PD Carey, ...
Clinical cancer research 10 (6), 2158-2167, 2004
2812004
A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with …
W Zhang, T Winder, Y Ning, A Pohl, D Yang, M Kahn, G Lurje, MJ Labonte, ...
Annals of Oncology 22 (1), 104-109, 2011
1762011
Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer
J Boyer, WL Allen, EG McLean, PM Wilson, A McCulla, S Moore, ...
Cancer research 66 (5), 2765-2777, 2006
1352006
Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer …
G Lurje, F Nagashima, W Zhang, D Yang, HM Chang, MA Gordon, ...
Clinical Cancer Research 14 (23), 7884-7895, 2008
1332008
Common cancer stem cell gene variants predict colon cancer recurrence
A Gerger, W Zhang, D Yang, P Bohanes, Y Ning, T Winder, MJ LaBonte, ...
Clinical Cancer Research 17 (21), 6934-6943, 2011
1082011
DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines
MJ LaBonte, PM Wilson, W Fazzone, S Groshen, HJ Lenz, RD Ladner
BMC medical genomics 2, 1-20, 2009
1082009
A novel fluorescence-based assay for the rapid detection and quantification of cellular deoxyribonucleoside triphosphates
PM Wilson, MJ LaBonte, J Russell, S Louie, AA Ghobrial, RD Ladner
Nucleic acids research 39 (17), e112-e112, 2011
1062011
Molecular markers in the treatment of metastatic colorectal cancer
PM Wilson, MJ LaBonte, HJ Lenz
The Cancer Journal 16 (3), 262-272, 2010
1052010
Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
A Gerger, A El-Khoueiry, W Zhang, D Yang, H Singh, P Bohanes, Y Ning, ...
Clinical Cancer Research 17 (17), 5783-5792, 2011
1032011
Novel opportunities for thymidylate metabolism as a therapeutic target
PM Wilson, W Fazzone, MJ LaBonte, J Deng, N Neamati, RD Ladner
Molecular cancer therapeutics 7 (9), 3029-3037, 2008
1032008
The dual EGFR/HER2 inhibitor lapatinib synergistically enhances the antitumor activity of the histone deacetylase inhibitor panobinostat in colorectal cancer models
MJ LaBonte, PM Wilson, W Fazzone, J Russell, SG Louie, A El-Khoueiry, ...
Cancer research 71 (10), 3635-3648, 2011
972011
Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells
W Fazzone, PM Wilson, MJ LaBonte, HJ Lenz, RD Ladner
International Journal of Cancer 125 (2), 463-473, 2009
932009
Inhibition of dUTPase induces synthetic lethality with thymidylate synthase–targeted therapies in non–small cell lung cancer
PM Wilson, MJ LaBonte, HJ Lenz, PC Mack, RD Ladner
Molecular cancer therapeutics 11 (3), 616-628, 2012
802012
Germline Polymorphisms in Genes Involved in the IGF1 Pathway Predict Efficacy of Cetuximab in Wild-type KRAS mCRC Patients
T Winder, W Zhang, D Yang, Y Ning, P Bohanes, A Gerger, PM Wilson, ...
Clinical Cancer Research 16 (22), 5591-5602, 2010
652010
Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage
PM Wilson, W Fazzone, MJ LaBonte, HJ Lenz, RD Ladner
Nucleic acids research 37 (1), 78-95, 2009
652009
The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells
WL Allen, EG McLean, J Boyer, A McCulla, PM Wilson, V Coyle, ...
Molecular cancer therapeutics 6 (1), 128-137, 2007
632007
A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy
PM Wilson, A El-Khoueiry, S Iqbal, W Fazzone, MJ LaBonte, S Groshen, ...
Cancer chemotherapy and pharmacology 65, 979-988, 2010
622010
Calbindin 2 (CALB2) regulates 5-fluorouracil sensitivity in colorectal cancer by modulating the intrinsic apoptotic pathway
L Stevenson, WL Allen, I Proutski, G Stewart, L Johnston, K McCloskey, ...
PloS one 6 (5), e20276, 2011
472011
The system can't perform the operation now. Try again later.
Articles 1–20